Frank E. Holmes - 30 Mar 2026 Form 3 Insider Report for HIVE Digital Technologies Ltd. (HIVE)

Reporting relationship: Executive Chairman, Director
Issuer ticker: HIVE
Reported as of: 30 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 31 Mar 2026, 16:56:58 UTC
Prior SEC filing: 02 Mar 2026
Next SEC filing: 01 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Frank E. Holmes

Key filing fact

Frank E. Holmes filed Form 3 for HIVE Digital Technologies Ltd. (HIVE) on 31 Mar 2026.

Key facts

This page summarizes Frank E. Holmes's Form 3 filing for HIVE Digital Technologies Ltd. (HIVE).
0 reported transactions and 11 derivative rows are listed below.
Accepted by SEC: 31 Mar 2026, 16:56.

Change

Previous filing in this sequence was filed on 02 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001251824 Primary reporting owner

HOLMES FRANK E

Relationship: Executive Chairman, Director
Address: 7900 CALLAGHAN ROAD, SUITE 128, SAN ANTONIO
Signature: /s/ Frank E. Holmes
Signature date: 30 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HIVE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 425,000
Date: 30 Mar 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HIVE holding Derivative

Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 500,000
Exercise price: $1.08
Footnotes: F1, F2

HIVE holding Derivative

Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $1.05
Footnotes: F3, F4

HIVE holding Derivative

Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,000
Exercise price: $4.94
Footnotes: F5, F6

HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 250,000
Exercise price: $0.000000
Footnotes: F7

HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 405,625
Exercise price: $0.000000
Footnotes: F8

HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 500,000
Exercise price: $0.000000
Footnotes: F9

HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 200,000
Exercise price: $0.000000
Footnotes: F10

HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 400,000
Exercise price: $0.000000
Footnotes: F11

HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 400,000
Exercise price: $0.000000
Footnotes: F12

HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 400,000
Exercise price: $0.000000
Footnotes: F13

HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 400,000
Exercise price: $0.000000
Footnotes: F14

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 14 footnotes

Footnote F1

These options were granted on September 14, 2017 and are fully vested as of the date hereof.

Footnote F2

Represents an exercise price of $1.50 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026.

Footnote F3

These options were granted on February 10, 2020 and are fully vested as of the date hereof.

Footnote F4

Represents an exercise price of $1.45 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026.

Footnote F5

These options were granted on July 6, 2023 and are fully vested as of the date hereof.

Footnote F6

Represents an exercise price of $6.86 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026.

Footnote F7

Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of common stock. The RSUs were issued on August 26, 2022 and are fully vested as of the date hereof.

Footnote F8

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on July 18, 2024 and are fully vested as of the date hereof.

Footnote F9

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on November 5, 2024. 312,50 RSUs are fully vested, and the remaining 187,500 vest in three equal installments of on each of May 5, 2026, August 6, 2026 and November 6, 2026.

Footnote F10

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on February 14, 2025 and are fully vested as of the date hereof.

Footnote F11

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on April 17, 2025 and will vest in one installment on April 17, 2026.

Footnote F12

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on July 8, 2025 and will vest in one installment on July 8, 2026.

Footnote F13

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on October 31, 2025 and will vest in one installment on October 31, 2026.

Footnote F14

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on March 16, 2026 and will vest in one installment on March 16, 2027.

SEC remarks

The Board of Directors of HIVE Digital Technologies Ltd. (the "Company" ) has determined that the Company no longer qualifies as a foreign private issuer. As a result, effective April 1, 2026, the Company is required to comply with the reporting requirements and use the filing forms applicable to U.S. public companies under U.S. securities laws, including reports required under Section 16 of the U.S. Securities Exchange Act of 1934, as amended. The Reporting Person is filing this Form 3 in connection with this transition. Exhibit 24 Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .